Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 25.


de Knegt, Gerjo J, Dickinson, Laura ORCID: 0000-0001-5557-9396, Pertinez, Henry, Evangelopoulos, Dimitrios, McHugh, Timothy D, Bakker-Woudenberg, Irma AJM, Davies, Gerry R ORCID: 0000-0002-3819-490X and de Steenwinkel, Jurriaan EM
(2017) Assessment of treatment response by colony forming units, time to culture positivity and the molecular bacterial load assay compared in a mouse tuberculosis model. TUBERCULOSIS, 105. pp. 113-118.


De Francesco, Davide, Wang, Xinzhu, Dickinson, Laura ORCID: 0000-0001-5557-9396, Underwood, Jonathan, Bagkeris, Emmanouil, Babalis, Daphne S, Mallon, Patrick WG, Post, Frank A, Vera, Jaime H, Sachikonye, Memory
et al (show 5 more authors) (2021) Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV. PLOS ONE, 16 (7). e0253861-.


Fox, Julie, Tiraboschi, Juan M, Herrera, Carolina ORCID: 0000-0003-3701-752X, Else, Laura, Egan, Deirdre, Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil ORCID: 0000-0002-4574-544X, Olejniczak, Natalia, Back, David, Khoo, Saye ORCID: 0000-0002-2769-0967
et al (show 2 more authors) (2016) Brief Report: Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. Journal of acquired immune deficiency syndromes (1999), 73 (3). pp. 252-257.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Amin, Janaki, Else, Laura, Boffito, Marta, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, Catherine, Clarke, Amanda
et al (show 6 more authors) (2016) Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600 mg in Treatment-Naive HIV-Infected Patients at 96 Weeks: Results of the ENCORE1 Study. CLINICAL PHARMACOKINETICS, 55 (7). pp. 861-873.


Duwal, Sulav, Dickinson, Laura ORCID: 0000-0001-5557-9396, Khoo, Saye ORCID: 0000-0002-2769-0967 and von Kleist, Max
(2018) Hybrid stochastic framework predicts efficacy of prophylaxis against HIV: An example with different dolutegravir prophylaxis schemes. PLOS COMPUTATIONAL BIOLOGY, 14 (6). e1006155-.


Gini, Joshua, Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Dickinson, Laura ORCID: 0000-0001-5557-9396, Waitt, Catriona ORCID: 0000-0003-0134-5855, Neary, Megan ORCID: 0000-0002-4960-2139, Else, Laura J, Siccardi, Marco ORCID: 0000-0002-3539-7867 and Khoo, Saye ORCID: 0000-0002-2769-0967
(2019) Impact of pharmacogenetics and pregnancy on tenofovir and emtricitabine pharmacokinetics. PHARMACOGENOMICS, 20 (4). pp. 217-224.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Walimbwa, Stephen, Singh, Yashna, Kaboggoza, Julian, Kintu, Kenneth, Sihlangu, Mary, Coombs, Julie-Anne, Malaba, Thokozile R, Byamugisha, Josaphat, Pertinez, Henry
et al (show 11 more authors) (2021) Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1. CLINICAL INFECTIOUS DISEASES, 73 (5). E1200-E1207.


Gurjar, Rohan, Dickinson, Laura ORCID: 0000-0001-5557-9396, Carr, Daniel, Stohr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, De Castro, Nathalie, Fatkenheuer, Gerd
et al (show 6 more authors) (2022) Influence of <i>UGT1A1</i> and <i>SLC22A6</i> polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study. PHARMACOGENOMICS JOURNAL, 23 (1). pp. 14-20.


Duwal, Sulav, Dickinson, Laura ORCID: 0000-0001-5557-9396, Khoo, Saye ORCID: 0000-0002-2769-0967 and von Kleist, Max
(2019) Mechanistic framework predicts drug-class specific utility of antiretrovirals for HIV prophylaxis. PLoS computational biology, 15 (1). e1006740-e1006740.


Dickinson, Laura, Amin, J, Else, Laura, Boffito, M, Egan, Deirdre, Owen, Andrew ORCID: 0000-0002-9819-7651, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Orrell, C, Clarke, A
et al (show 6 more authors) (2015) Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naïve HIV-Infected Patients: Results of the ENCORE1 Study. Clinical pharmacology and therapeutics, 98 (4). pp. 406-416.


Fox, Julie, Tiraboschi, Juan M, Herrera, Carolina, Else, Laura, Egan, Deirdre, Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil, Olejniczak, Natalia, Back, David, Khoo, Saye ORCID: 0000-0002-2769-0967
et al (show 2 more authors) (2016) Pharmacokinetic/Pharmacodynamic Investigation of Single-Dose Oral Maraviroc in the Context of HIV-1 Pre-exposure Prophylaxis. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 73 (3). pp. 252-257.


Herrera, Carolina, Lwanga, Julianne, Lee, Ming, Mantori, Suna, Amara, Alieu ORCID: 0000-0002-1137-2948, Else, Laura, Penchala, Sujan Dilly, Egan, Deirdre, Challenger, Elizabeth ORCID: 0000-0002-8978-6067, Dickinson, Laura ORCID: 0000-0001-5557-9396
et al (show 4 more authors) (2021) Pharmacokinetic/pharmacodynamic investigation of raltegravir with or without lamivudine in the context of HIV-1 pre-exposure prophylaxis (PrEP). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 76 (8). pp. 2129-2136.


FitzGerald, Richard, Dickinson, Laura ORCID: 0000-0001-5557-9396, Else, Laura, Fletcher, Thomas, Hale, Colin, Amara, Alieu ORCID: 0000-0002-1137-2948, Walker, Lauren ORCID: 0000-0002-3827-4387, Penchala, Sujan Dilly, Lyon, Rebecca, Shaw, Victoria ORCID: 0000-0002-0429-0186
et al (show 9 more authors) (2022) Pharmacokinetics of ss-d-N4-Hydroxycytidine, the Parent Nucleoside of Prodrug Molnupiravir, in Nonplasma Compartments of Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection. CLINICAL INFECTIOUS DISEASES, 75 (1). E525-E528.


Wang, Xinzhu, Boffito, Marta, Dickinson, Laura ORCID: 0000-0001-5557-9396, Bagkeris, Emmanouil, Khoo, Saye ORCID: 0000-0002-2769-0967, Post, Frank A, Vera, Jaime, Williams, Ian, Ndoutoumou, Amalia, Anderson, Jane
et al (show 5 more authors) (2020) Plasma NRTI concentration and their associations with liver and renal parameters in people living with HIV. AIDS, 34 (5). pp. 790-793.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Yapa, H Manisha, Jackson, Akil ORCID: 0000-0002-4574-544X, Moyle, Graeme, Else, Laura, Amara, Alieu ORCID: 0000-0002-1137-2948, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Karolia, Zeenat, Higgs, Chris
et al (show 1 more authors) (2015) Plasma Tenofovir, Emtricitabine, and Rilpivirine and Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate Pharmacokinetics following Drug Intake Cessation. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 59 (10). pp. 6080-6086.


Wang, Xinzhu, Boffito, Marta, Dickinson, Laura ORCID: 0000-0001-5557-9396, Bagkeris, Emmanouil, Khoo, Saye, Post, Frank A, Vera, Jaime, Williams, Ian, Ndoutoumou, Amalia, Anderson, Jane
et al (show 5 more authors) (2020) Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV. AIDS, 34 (5). pp. 790-793.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Bracchi, Margherita, Elliot, Emilie, Else, Laura, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David, Nelson, Mark and Boffito, Marta
(2016) Population pharmacokinetics (PK) of dolutegravir (DTG) alone and following treatment switch. .


Dickinson, Laura ORCID: 0000-0001-5557-9396, Gurjar, Rohan, Stoehr, Wolfgang, Bonora, Stefano, Owen, Andrew ORCID: 0000-0002-9819-7651, D'Avolio, Antonio, Cursley, Adam, Molina, Jean-Michel, Faeetkenheuer, Gerd, Vandekerckhove, Linos
et al (show 5 more authors) (2020) Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 75 (3). pp. 628-639.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Winston, Alan, Boffito, Marta, Khoo, Saye ORCID: 0000-0002-2769-0967, Back, David and Siccardi, Marco ORCID: 0000-0002-3539-7867
(2016) Simulation of the impact of rifampicin on once-daily darunavir/ritonavir pharmacokinetics and dose adjustment strategies: a population pharmacokinetic approach. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 71 (4). pp. 1041-1045.


Dickinson, Laura ORCID: 0000-0001-5557-9396, Jackson, Akil ORCID: 0000-0002-4574-544X, Garvey, L, Watson, Victoria, Khoo, Saye ORCID: 0000-0002-2769-0967, Boffito, M, Davies, Geraint ORCID: 0000-0002-3819-490X and Back, David
(2012) Simultaneous population pharmacokinetic modelling of darunavir and ritonavir Once daily in HIV-infected patients: evaluation of lower ritonavir dose. Journal of the International AIDS Society, 15 (4).


Duwal, Sulav, Seeler, Daniel, Dickinson, Laura ORCID: 0000-0001-5557-9396, Khoo, Saye ORCID: 0000-0002-2769-0967 and von Kleist, Max
(2019) The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis. FRONTIERS IN PHARMACOLOGY, 10. 199-.


Duwal, Sulav, Seeler, Daniel, Dickinson, Laura ORCID: 0000-0001-5557-9396, Khoo, Saye ORCID: 0000-0002-2769-0967 and von Kleist, Max
(2019) The Utility of Efavirenz-based Prophylaxis Against HIV Infection. A Systems Pharmacological Analysis. Frontiers in pharmacology, 10 (MAR). p. 199.


Siccardi, Marco ORCID: 0000-0002-3539-7867, Dickinson, Laura ORCID: 0000-0001-5557-9396 and Owen, Andrew ORCID: 0000-0002-9819-7651
(2016) Validation of Computational Approaches for Antiretroviral Dose Optimization (vol 60, pg 3838, 2016). ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 61 (1). e02367-e02316.


Olagunju, Adeniyi ORCID: 0000-0002-6588-5749, Anweh, Damien, Okafor, Ogechi, Dickinson, Laura ORCID: 0000-0001-5557-9396, Richman, Douglas ORCID: 0000-0003-0962-9254, Owen, Andrew ORCID: 0000-0002-9819-7651 and Adejuyigbe, Ebunoluwa ORCID: 0000-0002-8671-4965
(2019) Viral and antiretroviral dynamics in HIV mother-to-child transmission fluids (VADICT) – Protocol and data analysis plan for a cohort study. Wellcome Open Research, 4. p. 34.


Wootton, Daniel G ORCID: 0000-0002-5903-3881, Dickinson, Laura ORCID: 0000-0001-5557-9396, Pertinez, Henry, Court, Joanne, Eneje, Odiri, Keogan, Lynne, Macfarlane, Laura, Wilks, Sarah, Gallagher, Jane, Woodhead, Mark
et al (show 2 more authors) (2017) A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. European Respiratory Journal, 49 (6). 1602170-.

This list was generated on Tue Apr 16 11:59:22 2024 BST.